Your trusted guide on the treatment journey.

From the first step to ongoing support, we’re with you every day and every way possible.

We’ve Got You Covered With Dedicated Support Throughout the Prescribing Process and Care at Every Step

1

Embark With Confidence

  • Enroll Your Patient
  • Prescribe Triptodur
2

Navigate Access and Coverage

  • Benefits Investigation and Prior Authorization
  • Copay Assistancea
3

We've Got You Covered

  • Triptodur CareSM Bridge Programb
  • Triptodur CareSM Patient Assistance Programc
4

Ongoing Support

  • Network Specialty Pharmacy with a 
single point of contact
  • Resources for HCPs, caregivers, patients

Call 833-401-CARE (2273), 8:00 AM – 5:00 PM ET, Monday through Friday.

1. Getting Started

Embark With Confidence

Let’s set the stage for success, from seamless enrollment to product access and navigating the insurance process, so you can relax knowing you’re starting off right.

Enroll Your Patient in Triptodur CareSM

To access all the benefits of Triptodur CareSM, including benefits investigation and support, enroll your patients now! Download and complete the Patient Enrollment Form (English / Español) and fax to (855) 246-3986.

The Triptodur CareSM team will fax your office a confirmation that we’ve received your patient’s Triptodur enrollment within 2 hours of receipt if received between 8:00 AM – 5:00 PM ET, Monday through Friday.

Accessing Triptodur

Triptodur is available through the Triptodur CareSM network pharmacy partner, your health system specialty pharmacy, or directly from your specialty distributor.

eRx
Submit a prescription for Triptodur via eRx
NPI: 1750843314

Phone
Call the Triptodur CareSM team at (833) 401-CARE (2273) 8:00 AM – 5:00 PM ET, Monday through Friday

Fax
Fax the completed Patient Enrollment Form (English/Español) to (855) 246-3986

2. We’ve got you Covered

Support Through the Process

Navigating potential access barriers to help patients receive their treatment 
as prescribed.

Benefit Investigation (BI) and Prior Authorization (PA) Through Approval

Triptodur CareSM will conduct a BI, and if insurance requires a PA or appeal we will assist with documentation and processing.

Please keep the Triptodur CareSM team informed of any direct communication that comes from the health plan, including approvals or denials.

95% approval rates when utilizing Triptodur CareSM.

Triptodur CareSM Copay Assistance

Eligible patientsa may pay as little as $5

95% of commercially insured eligible patientsa pay $5 or less for Triptodur

Download Copay Reimbursement Form

aSee Terms and Conditions.

3. Coverage that Cares

Rest Easy, We’ve Got You Covered

Providing additional coverage options for eligible patients who need it

Triptodur CareSM Bridge Program

Enables eligible, insured patientsa to receive Triptodur at no cost for the first fill to bridge the time it takes to get coverage for their prescribed treatment.

Download Bridge Program Form

aSee Terms and Conditions.

Triptodur CareSM Patient Assistance Program (PAP)

Approved eligible patientsa may receive medications at no cost, based on eligibility criteria..

Download Patient Assistance Program Form

aSee Terms and Conditions.

4. Continuous Support

Here Every Step of the Way

Now that you’re on the path, our team is here to provide unwavering support, from guidance on injections to answering questions.

We have a dedicated Triptodur CareSM team for streamlined support to both caregivers and healthcare providers.

Network Specialty Pharmacy

Use our network pharmacy partner to ensure a single point of contact to assist you in completing your tasks.

Medication shipment coordination

  • The Triptodur CareSM team will reach out to your practice and the caregiver to schedule shipment of the medication around the injection appointment
  • Triptodur must be administered by a healthcare provider

In-Home Nurse Injection Program

Patients whose prescriptions are filled through the network specialty pharmacy may receive in-home injections by a trained nurse at no cost with provider approval. Enroll by faxing the In-Home Nurse Referral Form to 877-650-7041.

Download In-Home Nurse Injection Program Form

Resources for HCPs, Caregivers, and Patients

Live in-service support and video guide for administering Triptodur.

Get started with Trip, the lovable dinosaur whose story helps explain what CPP is and what to expect with treatment. Also includes a storybook and is delivered in a Triptodur bag.

IMPORTANT SAFETY INFORMATION FOR TRIPTODUR

INDICATION

TRIPTODUR is indicated for the treatment of pediatric patients 2 years of age and older with central precocious puberty (CPP).

IMPORTANT SAFETY INFORMATION

Contraindications

TRIPTODUR is contraindicated in:

  • Individuals with a known hypersensitivity to triptorelin or any other component of the product, or other GnRH agonists or GnRH.
  • Women who are or may become pregnant. Expected hormonal changes that occur with TRIPTODUR treatment increase the risk for pregnancy loss and fetal harm when administered to a pregnant woman. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be advised of the potential risk to the fetus.

Warnings and Precautions

Initial Rise of Gonadotropins and Sex Steroid Levels – During the early phase of therapy, gonadotropins and sex steroids rise above baseline because of the initial stimulatory effect of the drug. Therefore, a transient increase in clinical signs and symptoms of puberty, including vaginal bleeding, may be observed during the first weeks of therapy or after subsequent doses.

Psychiatric Events – Psychiatric events have been reported in patients taking GnRH agonists. Postmarketing reports with this class of drugs include symptoms of emotional lability, such as crying, irritability, impatience, anger, and aggression. Monitor for development or worsening of psychiatric symptoms during treatment with TRIPTODUR.

Convulsions – Postmarketing reports of convulsions have been observed in patients receiving GnRH agonists, including triptorelin. These included patients with a history of seizures, epilepsy, cerebrovascular disorders, central nervous system anomalies or tumors, and patients on concomitant medications that have been associated with convulsions such as bupropion and SSRIs. Convulsions have also been reported in patients in the absence of any of the conditions mentioned above.

Pseudotumor Cerebri (idiopathic intracranial hypertension) – has been reported in pediatric patients receiving GnRH agonists, including triptorelin. Monitor patients for signs and symptoms of pseudotumor cerebri, including headache, papilledema, blurred vision, diplopia, loss of vision, pain behind the eye or pain with eye movement, tinnitus, dizziness, and nausea.

Adverse Reactions

In clinical trials for TRIPTODUR, the most common adverse reactions (≥4.5%) are injection site reactions, menstrual (vaginal) bleeding, hot flush, headache, cough, and infections (bronchitis, gastroenteritis, influenza, nasopharyngitis, otitis externa, pharyngitis, sinusitis, and upper respiratory tract infection).

To report SUSPECTED ADVERSE REACTIONS, contact Azurity Pharmaceuticals, Inc. at 1-800-461-7449, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

The Important Safety Information does not include all the information needed to use TRIPTODUR safely and effectively. For additional safety information, please consult the full Prescribing Information for TRIPTODUR.